Related references
Note: Only part of the references are listed.Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial
Michael J. Fisher et al.
NATURE MEDICINE (2021)
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas
Brian D. Weiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Acceptance and commitment therapy for adolescents and adults with neurofibromatosis type 1, plexiform neurofibromas, and chronic pain: Results of a randomized controlled trial
Staci Martin et al.
JOURNAL OF CONTEXTUAL BEHAVIORAL SCIENCE (2021)
Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1
Shivani Ahlawat et al.
NEUROLOGY (2021)
Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1 A Survey-Based Assessment
Shivani Ahlawat et al.
NEUROLOGY (2021)
Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1
Magdalena Koczkowska et al.
HUMAN MUTATION (2020)
Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1
Charlie N. Nelson et al.
JOURNAL OF NEUROSURGERY (2020)
Intermittent Versus Continuous Dosing of MAPK Inhibitors in Treatment of BRAF-Mutated Melanoma
Coralie Reger de Moura et al.
TRANSLATIONAL ONCOLOGY (2020)
Phase II trial of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886 Hydrogen Sulfate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).
Geraldine Helen O'Sullivan Coyne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1
Lennart Well et al.
PLOS ONE (2020)
Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions
Srivandana Akshintala et al.
NEURO-ONCOLOGY (2020)
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Andrea M. Gross et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform Neurofibromas
Lauren H. Boal et al.
CLINICAL CANCER RESEARCH (2020)
Long-TermResponse to Intermittent Binimetinib in Patients withNRAS-Mutant Melanoma
Alexandra Valeska Matter et al.
ONCOLOGIST (2020)
Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation
Magdalena Koczkowska et al.
GENETICS IN MEDICINE (2019)
Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors
Alexander L. Chin et al.
NEUROSURGERY (2019)
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas
Alexander Pemov et al.
NEURO-ONCOLOGY (2019)
The Arg1038Gly missense variant in the NF1 gene causes a mild phenotype without neurofibromas
Eva Trevisson et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1
Smita Bhatia et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
Shivani Ahlawat et al.
NEUROLOGY (2019)
Absence of Efficacy of Everolimus in Neurofibromatosis 1-Related Plexiform Neurofibromas: Results from a Phase 2a Trial
Ouidad Zehou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging
Lennart Well et al.
NEURO-ONCOLOGY (2019)
Lifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into Adulthood
Sally E. Jensen et al.
JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS (2019)
Volumetric MRI Analysis of Plexiform Neurofibromas in Neurofibromatosis Type 1: Comparison of Two Methods
Wenli Cai et al.
ACADEMIC RADIOLOGY (2018)
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848
Magdalena Koczkowska et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
Douglas R. Stewart et al.
GENETICS IN MEDICINE (2018)
The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors
Christine S. Higham et al.
NEURO-ONCOLOGY (2018)
Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1
Andrea M. Gross et al.
NEURO-ONCOLOGY (2018)
Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)-associated plexiform neurofibroma: A phase I/IIa study.
Geoffrey Brian McCowage et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Retrospective audit of 957 consecutive 18F-FDG PET-CT scans compared to CT and MRI in 493 patients with different histological subtypes of bone and soft tissue sarcoma
Ruth E. Macpherson et al.
CLINICAL SARCOMA RESEARCH (2018)
Reliability of functional outcome measures in adults with neurofibromatosis 1
Rebecca L. Mullin et al.
SAGE OPEN MEDICINE (2018)
CRMP2 is necessary for Neurofibromatosis type 1 related pain
Aubin Moutal et al.
CHANNELS (2018)
Using a Qualitative Approach to Conceptualize Concerns of Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (pNF) Across the Lifespan
Jin-Shei Lai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire
Rosalie E. Ferner et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2017)
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview
Markku M. Miettinen et al.
HUMAN PATHOLOGY (2017)
Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors
Kelsey L. Watson et al.
JOURNAL OF NEUROSURGERY (2017)
Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1 Multidisciplinary Recommendations for Care
Robert A. Avery et al.
OPHTHALMOLOGY (2017)
Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients
Teresa Esposito et al.
NUTRIENTS (2017)
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1
D. Gareth R. Evans et al.
CLINICAL CANCER RESEARCH (2017)
Acceptance and Commitment Therapy (ACT) for Chronic Pain: A Systematic Review and Meta-Analyses
Laura S. Hughes et al.
CLINICAL JOURNAL OF PAIN (2017)
Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis
Lara Hilton et al.
ANNALS OF BEHAVIORAL MEDICINE (2017)
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T. Valentin et al.
EUROPEAN JOURNAL OF CANCER (2016)
Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Elina Uusitalo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1
Scott R. Plotkin et al.
NEUROLOGY (2016)
Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT
Ana-Maria Vranceanu et al.
NEUROLOGY (2016)
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Pain Interference in Youth with Neurofibromatosis Type 1 and Plexiform Neurofibromas and Relation to Disease Severity, Social-Emotional Functioning, and Quality of Life
Pamela L. Wolters et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
Quantitative Associations of Scalp and Body Subcutaneous Neurofibromas with Internal Plexiform Tumors in Neurofibromatosis 1
Kimberly Jett et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation
Kitiwan Rojnueangnit et al.
HUMAN MUTATION (2015)
Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients
Mehdi Brahmi et al.
PLOS ONE (2015)
p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas
Valentina Pinna et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study
Brian Weiss et al.
NEURO-ONCOLOGY (2015)
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Nancy Ratner et al.
NATURE REVIEWS CANCER (2015)
A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands
R. van Minkelen et al.
CLINICAL GENETICS (2014)
Puberty and Plexiform Neurofibroma Tumor Growth in Patients with Neurofibromatosis Type I
Urania Dagalakis et al.
JOURNAL OF PEDIATRICS (2014)
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C. Widemann et al.
NEURO-ONCOLOGY (2014)
Sirolimus for Non-Progressive NF1-Associated Plexiform Neurofibromas: An NF Clinical Trials Consortium Phase II Study
Brian Weiss et al.
PEDIATRIC BLOOD & CANCER (2014)
Phase II Trial of Pirfenidone in Children and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Brigitte C. Widemann et al.
PEDIATRIC BLOOD & CANCER (2014)
Cognitive-Behavioral Therapy for Individuals With Chronic Pain Efficacy, Innovations, and Directions for Research
Dawn M. Ehde et al.
AMERICAN PSYCHOLOGIST (2014)
Visual Outcomes in Children With Neurofibromatosis Type 1 and Orbitotemporal Plexiform Neurofibromas
Robert A. Avery et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Recommendations for imaging tumor response in neurofibromatosis clinical trials
Eva Dombi et al.
NEUROLOGY (2013)
Functional outcome measures for NF1-associated optic pathway glioma clinical trials
Michael J. Fisher et al.
NEUROLOGY (2013)
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas
AeRang Kim et al.
PEDIATRIC BLOOD & CANCER (2013)
Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal/Hematopoietic Interactions in Tumor Progression
Karl Staser et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1
Carlos E. Prada et al.
JOURNAL OF PEDIATRICS (2012)
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
Kent A. Robertson et al.
LANCET ONCOLOGY (2012)
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1
Rosa Nguyen et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis
Scott R. Plotkin et al.
PLOS ONE (2012)
Social-emotional Functioning of Children and Adolescents With Neurofibromatosis Type 1 and Plexiform Neurofibromas: Relationships With Cognitive, Disease, and Environmental Variables
Staci Martin et al.
JOURNAL OF PEDIATRIC PSYCHOLOGY (2012)
Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Frequency and Associated Clinical Deficits
Rosa Nguyen et al.
JOURNAL OF PEDIATRICS (2011)
Phase I trial of pegylated interferon-α-2b in young patients with plexiform neurofibromas
R. I. Jakacki et al.
NEUROLOGY (2011)
Randomized controlled trials of psychological therapies for management of chronic pain in children and adolescents: An updated meta-analytic review
Tonya M. Palermo et al.
PAIN (2010)
GIANT PLEXIFORM NEUROFIBROMA WITH HEMORRHAGE IN CRANIO-MAXILLOFACIAL REGION AS DEPICTED ON CT AND MRI
Y. Feng et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2010)
Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas
A. Kim et al.
NEUROLOGY (2009)
Initial clinical experience with image-guided linear accelerator-based spinal radiosurgery for treatment of benign nerve sheath tumors
Michael T. Selch et al.
SURGICAL NEUROLOGY (2009)
Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas
T. Tucker et al.
JOURNAL OF MEDICAL GENETICS (2009)
Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/- and c-kit-Dependent Bone Marrow
Feng-Chun Yang et al.
CELL (2008)
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
Victor-F. Mautner et al.
NEURO-ONCOLOGY (2008)
Radiosurgery for benign intradural spinal tumors
Peter C. Gerszten et al.
NEUROSURGERY (2008)
Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1
J. R. Leonard et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas
Dusica Babovic-Vuksanovic et al.
PEDIATRIC NEUROLOGY (2007)
NF1 plexiform neurofibroma growth rate by volumetric MRI - Relationship to age and body weight
E. Dombi et al.
NEUROLOGY (2007)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation
M. Upadhyaya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Phase II trial of pirfenidone in adults with neurofibromatosis type 1
D. Babovic-Vuksanovic et al.
NEUROLOGY (2006)
Second primary tumors in neurofibromatosis I patients treated for optic glioma: Substantial risks after radiotherapy
Saba Sharif et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1
VF Mautner et al.
NEURORADIOLOGY (2006)
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas
BC Widemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
MR imaging of abdominopelvic involvement in neurofibromatosis type 1: a review of 43 patients
TT Zacharia et al.
PEDIATRIC RADIOLOGY (2005)
Superficial neurofibroma: A lesion with unique MRI characteristics in patients with neurofibromatosis type 1
R Lim et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2005)
MR neurography and muscle MR imaging for image diagnosis of disorders affecting the peripheral nerves and musculature
AG Filler et al.
NEUROLOGIC CLINICS (2004)
Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1
A Gupta et al.
NEUROLOGY (2003)
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2002)
Schwann cells harbor the somatic NF1 mutation in neurofibromas:: evidence of two different Schwann cell subpopulations
E Serra et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
